Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate, rivastigmine or haloperidol in hypoactive delirious intensive care patients
2007-003965-42Phase 4Terminated
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of rivastigmine, methylphenidate and haloperidol in delirium (4 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Feasibility of large randomized controlled trial. Started Oct 2007; status: terminated.
02
Drugs
rivastigminemethylphenidatehaloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on 2007-003965-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003965-42.